Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page
- Check4 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating an update to the page's metadata. There are no changes to the study content visible on the page.SummaryDifference0.0%

- Check11 days agoChange DetectedThe results status in the study record changed from 'No Results Posted' to 'Results Submitted'. This indicates that trial results have been submitted for posting and are awaiting publication.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new release of the page. This reflects an internal deployment that may include fixes or enhancements to the page’s presentation or underlying systems.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a website/system update rather than a change to the study record content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe study status is updated to Completed with new dates (2026-04-15; 2026-03-05; 2026-04-07; 2026-04) and revision v3.5.2, and the previous Active, not recruiting status along with its earlier dates and revision v3.5.0 were removed.SummaryDifference0.4%

- Check83 days agoChange DetectedSite revision tag updated to Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.